Tag: GLP-1

ŌURA and LillyDirect to Expand Support for People Using GLP-1 Therapies with New Tools and Savings Options
Partnerships & Collaborations Sleep Pharmaceuticals

ŌURA and LillyDirect to Expand Support for People Using GLP-1 Therapies with New Tools and Savings Options

ŌURA maker of the world’s most trusted smart ring, Oura Ring, and LillyDirect, Eli Lilly and Company’s digital health platform designed to connect people living with chronic conditions to the care, support, and prescribed medicines they need, today announced a collaboration enabling savings on the Oura Ring sizing kit. The […]

Continue Reading →
New SANSA Platform Enhancements & Cardiovascular Risk Data to be Presented at SLEEP 2026
Industry News & Updates Technology & Innovation

Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker

Huxley Medical, a commercial-stage medical technology company expanding access to sleep apnea testing across health systems, cardiology, and primary care, today introduced two additions to its SANSA® platform: SANSA GO™, a point-of-care enrollment model that enables clinics to dispense SANSA at patient visits, and hypoxic burden, an additional measure of […]

Continue Reading →